A specific license for human use of radioactive material in institutions shall be issued only if the requirements of §§ 6910.2 through 6910.6 are satisfied.
The applicant shall appoint and submit to the Director the names of the members of a medical radiation safety committee of at least three (3) members to evaluate all proposals for research, diagnostic, and therapeutic use of radioisotopes within that institution.
Membership of the medical radiation safety committee required by § 6910.1 shall include physicians expert in internal medicine, hematology, and therapeutic radiology, and a person experienced in testing of radioisotopes and protection against radiation.
The applicant shall possess adequate facilities for the clinical care of patients.
The physician designated on the application as the individual user shall have substantial experience in the handling and administration of radioisotopes and, where applicable, the clinical management of radioactive patients.
If the application is for the license to use unspecified quantities or multiple types of radioactive material, the applicant's staff shall have substantial experience in the use of radioactive materials for a variety of human uses.
A specific license for the human use of radioactive materials shall be issued to an individual physician only if the applicant satisfies the following requirements:
A specific license for human use of sealed sources shall be issued only if the applicant or, if the application is made by an institution, the individual user meets the following requirements:
An application for a specific license pursuant to §§ 6910.1 through 6910.7 of this section for any diagnostic use of radioactive material in humans as specified in standards issued by the Director shall be approved for all of the diagnostic uses within the standards if the applicant satisfies the following requirements:
D.C. Mun. Regs. tit. 22, r. 22-B6910